David Piccioni

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

Jason K. Sicklick, Shumei Kato, Ryosuke Okamura et al. · Nature Medicine · 2019 · 720 citations · Full text

Medicine, Molecular Medicine, Oncology +17

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 540 citations · Full text

Medicine, Immunology, Oncology +17

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 405 citations · Full text

Medicine, Immunology, Oncology +17

Prevalence of<i>PDL1</i>Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors

Aaron M. Goodman, David Piccioni, Shumei Kato et al. · JAMA Oncology · 2018 · 245 citations · Full text

Life Sciences, Oncology, Pathology +17

ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases

Priya Kumthekar, Shou‐Ching Tang, Andrew Brenner et al. · Clinical Cancer Research · 2020 · 243 citations

Medicine, Oncology, Pharmacology +17